neuromuscular

/Tag:neuromuscular

What Happened to the FDA Request for Transvaginal Mesh Studies?

September 19, 2012 ~ Last January, after a five-fold increase in complications was noted by the U.S. Food and Drug Administration (FDA) concerning synthetic mesh used in women to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the FDA ordered mesh makers to find out why. At the Read more

By | 2017-04-20T12:55:49+00:00 September 19th, 2012|FDA News|5 Comments
Interested in our free Mesh webinar? Learn More
Webinar Starts